While the prices of drugs of the first line and second line treatment have continued to fall, third line treatment remains expensive. "There are obviously not enough generic drugs in the market that is pushing up the costs. With more and more people already on second line drugs, doctors say that soon the number of patients needing third line drugs is going to rise substantially. The third line drugs are needed by people who have become resistant to other drugs. Untangling the Web of Antiretroviral Price ReductionsPrices of older HIV drugs continue to declineNewer drugs remain largely priced out of reachPharmaceutical corporations maintain monopolies blocking generic competition

Source: dna July 22, 2016 02:15 UTC